Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety (Q46661382)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety |
scientific article |
Statements
1 reference
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety (English)
1 reference
Kelley SK
1 reference
Harris LA
1 reference
Xie D
1 reference
Deforge L
1 reference
Totpal K
1 reference
Bussiere J
1 reference
Fox JA
1 reference
1 October 2001
1 reference
299
1 reference
1
1 reference
31-38
1 reference
Identifiers
1 reference